Advertisement

Topics

Shorter course of treatment may provide better outcome for intermediate-risk prostate cancer

19:00 EST 4 Dec 2017 | AAAS

(Brigham and Women's Hospital) Researchers found that the one-month duration HRT, was associated with a significant improvement in prostate cancer recurrence compared to the two-month duration CRT and therefore would be reasonable to consider in men with intermediate risk prostate cancer who do not have risk factors that could predispose the patient to bladder side effects several years after the treatment is complete.

Original Article: Shorter course of treatment may provide better outcome for intermediate-risk prostate cancer

NEXT ARTICLE

More From BioPortfolio on "Shorter course of treatment may provide better outcome for intermediate-risk prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...